Skip to main content

PROASSURANCE ALERT: Bragar Eagel & Squire, P.C. is Investigating ProAssurance Corporation on Behalf of Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against ProAssurance Corporation (NYSE: PRA) on behalf of ProAssurance stockholders. Our investigation concerns whether ProAssurance has violated the federal securities laws and/or engaged in other unlawful business practices.

Click here to participate in the action.

On January 22, 2020, ProAssurance disclosed a $37 million charge to its loss reserves for fourth quarter 2019 due to “deteriorating loss experience, driven by a large national healthcare account.”

On this news, the Company’s stock price fell $4.81 per share, or nearly 13%, to close at $33.40 per share on January 23, 2020.

If you purchased or otherwise acquired ProAssurance shares and suffered a loss, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Marion Passmore or Melissa Fortunato by email at investigations@bespc.com, or telephone at (646) 860-9156, or by filling out this contact form. There is no cost or obligation to you.

About Bragar Eagel & Squire, P.C.:

Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts:

Bragar Eagel & Squire, P.C.
Melissa Fortunato, Esq.
Marion Passmore, Esq.
(646) 860-9156
investigations@bespc.com
www.bespc.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.